Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid in Gender Mastectomy
NCT04372940Phase 4Withdrawn
- Sponsor
- University of Wisconsin–Madison
- Start
- Jan 2023
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tranexamic acid, sponsored by University of Wisconsin–Madison. Planned start Jan 2023; status: withdrawn.
02
Drugs
tranexamic acid
Beyond the preview
Go deeper on NCT04372940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04372940.